Marrone Bio Innovations Appoints Lara L. Lee to Board of Directors
November 02 2020 - 04:05PM
Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an
international leader in providing growers with sustainable
bioprotection and plant health solutions to support global
agricultural needs, today announced the appointment of prominent
business leader Lara L. Lee to the Board of Directors.
Lara L. Lee brings over 30 years of experience
leading growth and transformation for iconic brands around the
world, including Harley‐Davidson and Lowe’s. She currently serves
on the boards of Organically Grown Company, a progressive organic
produce distributor with international sourcing operations, and The
Sill, a direct-to-consumer retailer of house plants. From 2013‐2018
Lara was an officer and SVP at Lowe’s Home Improvement, where she
was instrumental in the company’s omni‐channel transformation to
offer a distinct, relevant brand experience across digital, social
physical and human touch‐points, and served as President of the
Orchard Supply Hardware subsidiary. Prior experience includes Chief
Innovation and Operating Officer at Continuum, a global
consultancy, and business unit leadership roles at
Harley-Davidson.
Lara L. Lee obtained a B.A. in Chinese Language
from Brown University, a Master’s in International Studies from the
University of Pennsylvania and an MBA from The Wharton School. She
is a member of the National Association of Corporate Directors
(NACD) and Corporate Directors Forum.
“We are privileged to welcome someone with such
a prestigious background to the Marrone Bio Innovations board,”
said Bob Woods, Chairman of the Board of Directors of Marrone Bio
Innovations. “Lara brings valuable insights from a C‐suite
perspective, and experience with channel, market and digital
disruption with depth in innovation and strategic marketing. Her
work with international distribution and global brands will help us
guide the Company towards building a full-service biologicals
organization with scope and capabilities across the highest growth
segments in the industry, and to position Marrone Bio for the
strategic commercialization of its robust R&D pipeline. I
believe that Lara will help us expand the breadth and depth of the
Company’s reach and look forward to working with her to position
Marrone Bio to create value for our shareholders.”
“Marrone Bio is well positioned to become a
top-tier commercial-scale player in the biologicals space, with an
unrivaled product portfolio and thought leadership position. I look
forward to working with Bob and the Board of Directors to help
drive execution of the Company’s growth plans and broaden the
Company’s global reach,” added Lara L. Lee.
About Marrone Bio
InnovationsMarrone Bio Innovations Inc. (NASDAQ: MBII) is
a growth-oriented company leading the movement to a more
sustainable world through the discovery, development and sale of
innovative biological products for crop protection, plant health
and waterway systems treatment that help customers operate more
sustainably while increasing their return on investment. MBI has
screened over 18,000 microorganisms and 350 plant extracts,
leveraging its in-depth knowledge of plant and soil microbiomes
enhanced by advanced molecular technologies and natural product
chemistry to rapidly develop seven product lines. Supported by a
robust portfolio of over 400 issued and pending patents, MBI’s
currently available commercial products are Regalia®, Stargus®,
Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter™, Zelto® Jet
Oxide® and Jet Ag® and Zequanox®, with a next-generation
insecticide-nematicide, a breakthrough bioherbicide and a
biofumigant in the Company’s product pipeline. MBI’s Pro Farm
Finland-based subsidiary employs a proprietary technology derived
from wood waste to stimulate plant growth and improve plant health,
resulting in improved yields and crop quality. Products include
UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST.
Learn more about Marrone Bio Innovations at
www.marronebio.com. We also use our investor relations website,
https://investors.marronebio.com, as well as our corporate Twitter
account, @Marronebio, as means of disclosing material non-public
information, and encourage our investors and others to monitor and
review the information we make public in these locations. Follow us
on social media: Twitter, LinkedIn and Instagram.
Forward Looking Statements
This press release contains forward-looking
statements that involve substantial risks and uncertainties. All
statements, other than statements of historical facts, included in
this press release regarding strategy, future operations and plans,
including assumptions underlying such statements, are
forward-looking statements, and should not be relied upon as
representing the views of Marrone Bio Innovations, Inc. (“MBI”) as
of any subsequent date. Examples of such statements include
statements regarding the potential benefits from Ms. Lee joining
the board of directors and the company’s goals for future
performance. Such forward-looking statements are based on
information available to MBI as of the date of this release and
involve a number of risks and uncertainties, some beyond MBI’s
control, that could cause actual results to differ materially from
those anticipated by these forward-looking statements, including
the recent uncertainty in the global economy and industry-specific
economy caused by the COVID-19 pandemic, consumer, regulatory and
other factors affecting demand for MBI’s products, any difficulty
in marketing MBI’s products in global markets, competition in the
market for pest management products, lack of understanding of
bio-based pest management products by customers and growers,
adverse decisions by regulatory agencies and other relevant third
parties and any difficulty in integrating the acquired businesses.
Additional information that could lead to material changes in MBI’s
performance is contained in its filings with the Securities and
Exchange Commission. MBI is under no obligation to, and expressly
disclaims any responsibility to, update or alter forward-looking
statements contained in this press release, whether as a result of
new information, future events or otherwise.
Company Contact:Kevin Helash, Chief Executive
OfficerPhone: 530-750-2800info@marronebio.com
Investor Relations Contact:Greg Falesnik or
Luke ZimmermanMZ Group – MZ North AmericaPhone:
949-385-6449MBII@mzgroup.us
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Feb 2024 to Mar 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Mar 2023 to Mar 2024